Replies to post #442519 on Anavex Life Sciences Corp (AVXL)

[kevindenver]

Such is the art of the soft bash response to deviate into FUD narratives.

[Investor2014]

I identified two questions in your post:

1) Why did the PDD trial description trigger you?
2) As an investor in Anavex, were you upset by its promising results?

I gave you the following answer:

Forgive me for thinking that a PDD trial full data peer reviewed paper still not being published after 3 years of Anavex promising one is a bit late, especially considering how promising you feel the partial results were.

To elaborate, the title of the PDD trial was: "A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of ANAVEX2-73 for Cognitive Impairment in Patients With Parkinson's Disease With Dementia", which in the readout PR Anavex labeled a "Proof of Concept" P2 trial as it did not readout all the defined outcome measures and still hasn't e.g. in the now 3 years expected and awaited peer reviewed PDD trial data publication.

If the results were as promising as you intimate, it seems to me just a tad odd that Anavex have done absolute nothing since with the Parkinson's indication, other than to state further so far unmet catalyst events.

All indisputable facts that I am sure someone will protest are not, but without providing evidence to the contrary.